Sequence information


DRAVP ID  DRAVPc039

Name   Astegolimab

Sequence 

Molecular Formula  Not Available

Condition/Disease  COVID-19

Group  Phase â…ˇclinical trial

Type  Antibody

Description  Astegolimab is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).

Active sequence/Structure 


External Links


DrugBank Accession Number  DB16386

Pubchem ID  402425721

CHEMBL ID  CHEMBL4594385

UNII  27TW751DTH

CAS  2173054-79-8

Reference  Not Available



ClinicalTrails Information


NCT Number Study Title Condition/Disease Status Phase Sponsor
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL) COVID-19 Pneumonia / Coronavirus Disease 2019 (COVID‑19) Treatment Completed Phase 2 Genentech, Inc.